Registered entities
Shape Therapeutics Inc.
Reg. No. 825230989United States
Innovation
62 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 1,327 times.
| Year | Filings |
|---|---|
| 2021 | 11 |
| 2022 | 12 |
| 2023 | 27 |
| 2024 | 29 |
| 2025 | 31 |
| 2026 | 12 |
Social engagement
Social engagement: 13K social following, 5 posts in the last 12 months — around the industry typical range.
Investor mix
8 investors on record; lead investors include Decheng Capital, Breton Capital Ventures, New Enterprise Associates.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 75% |
| Angel & family office | 1 | 13% |
| Other / undisclosed | 1 | 13% |
Recent activity
29 Jun 2026
Product launch
RNAfix for Rett syndrome
26 Sep 2025
Event
ESGCT 2025 conference
18 Sep 2025
Partnership
VectorY Therapeutics